Biotech News

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

BioNano Genomics (BNGO)BioNano GenomicsCompany update

SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome Mapping (OGM).

Related news

BioNano Genomics

Genome Analysis Platform Bionano provides optical genome mapping systems and software for identifying structural variants and interpreting genomic data. Saphyr and OGM The Saphyr platform images ultra-high-molecular-weight DNA to detect large genomic changes that can be missed by conventional cytogenetics or short-read sequencing. VIA...

Recent company news

Stock data

Close
1.20 USD
Market cap
14.46M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States